Abstract
Annual screening for microalbuminuria will allow the identification of patients with nephropathy at a point very early in its course. Improving glycemic control, aggressive antihypertensive treatment, and the use of ACE inhibitors will slow the rate of progression of nephropathy. In addition, protein restriction and other treatment modalities such as phosphate lowering may have benefits in selected patients.
Source and rights
Published by Diabetes care, 2000. The guideline itself is at the source linked here.
Prognia summarises this guideline for reference and education. It is not medical advice. Always check the official guideline and current local protocols before acting on it.
At a glance
- Published
- 2000
- Applies to
- 🇺🇸 United States
- Scope
- National
- Journal
- Diabetes care
- PubMed
- 12017684
- Added to Prognia
- 25 July 2026
